2025-07-29 - Analysis Report
Okay, here's an analysis of Meta Platforms Inc. (META) based on the provided data, presented in a structured format with a focus on key performance indicators and recent developments.

## Meta Platforms Inc. (META) Stock Analysis

**Ticker:** META
**Company Description:** Meta Platforms Inc. is a global technology company that develops and operates various social media platforms and technologies.

### 1. Performance vs. S&P 500 (VOO)

*   **META Cumulative Return:** 146.02%
*   **VOO Cumulative Return:** 99.63%
*   **Absolute Divergence:** 45.8 (META outperformed VOO by 45.8 percentage points)
*   **Relative Divergence:** 86.8 (Current divergence is at the 86.8th percentile of historical divergence range).

**Analysis:**  META has significantly outperformed the S&P 500. The relative divergence indicates that this outperformance is historically high, suggesting the stock is currently performing very well compared to its benchmark.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2015-2017  | 48.0%   | 54.4%   | 19.0%   | -0.0  | 443.7  |
| 2016-2018  | -19.0%  | 71.1%   | -37.0%  | -0.0  | 329.6  |
| 2017-2019  | 18.0%   | 71.1%   | -12.0%  | -0.1  | 516.1  |
| 2018-2020  | 3.0%    | 71.1%   | -17.0%  | 0.7   | 686.8  |
| 2019-2021  | 45.0%   | 59.5%   | -3.0%   | 0.9   | 845.7  |
| 2020-2022  | -77.0%  | 68.6%   | -79.0%  | 0.8   | 302.6  |
| 2021-2023  | -10.0%  | 69.4%   | -28.0%  | -0.6  | 890.0  |
| 2022-2024  | 54.0%   | 77.7%   | 28.0%   | -0.8  | 1472.2 |
| 2023-2025  | 176.0%  | 77.7%   | 124.0%  | 0.5   | 1804.4 |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate varies significantly across the periods, with a notable high of 176.0% in the 2023-2025 period.
*   **MDD:** Maximum Drawdown figures are substantial, indicating periods of significant losses.
*   **Alpha:**  Alpha fluctuates considerably, with the most recent period (2023-2025) showing a very high positive alpha (124.0%), reflecting substantial outperformance relative to its risk-adjusted benchmark.
*   **Beta:**  Beta values are generally low, and some periods exhibit negative betas.
*   **Cap(B):** Market capitalization has generally increased, especially in the later periods.

### 2. Recent Stock Price Movement

*   **Current Price:** $717.63
*   **Previous Close:** $712.68
*   **Change:** +0.69%
*   **5-Day Moving Average:** 712.7
*   **20-Day Moving Average:** 716.52
*   **60-Day Moving Average:** 678.32

**Analysis:** The current price is above the 5-day and 20-day moving averages, suggesting short-term positive momentum. It's also significantly above the 60-day moving average, indicating a strong longer-term upward trend. The positive change from the previous close confirms recent upward price action.

### 3. Market Risk Indicators & Expected Return

*   **MRI:** 0.3286 (Low Risk)
*   **RSI:** 48.25 (Neutral)
*   **PPO:** -0.3412
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (1 shares - Caution - MRI:0.34) (Cash Ratio: 69% on 2025-07-14)
*   **Delta_Previous_Relative_Divergence:** -1.3 (Short-term decline)
*   **Expected Return:** -9.6% (Over S&P 500 for long-term investment)

**Analysis:**

*   The Low-Risk MRI indicates a stable market environment.
*   The RSI is near the neutral level, implying neither overbought nor oversold conditions.
*   The negative PPO value indicates that the shorter-term moving average is below the longer-term moving average, potentially suggesting a slight downtrend.
*   The Hybrid Signal suggests selling a small portion of holdings and keeping a high cash ratio (69%), implying caution.
*   Delta_Previous_Relative_Divergence is negative, indicating the recent relative performance of the stock is declining.
*   The negative expected return suggests that, based on the model, META is expected to underperform the S&P 500 over a long-term investment horizon.

### 4. Recent News & Significant Events

*   **[2025-07-26]:** Meta Platforms Inc (META) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-25]:** Analysts are discussing Meta Platforms Inc's (META) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-07-27]:** Meta Platforms Inc (META)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-29]:** Market experts highlight both risks and opportunities for Meta Platforms Inc (META), advising investors to monitor recent news and company announcements.

**Analysis:** Recent news indicates potential volatility and significant developments affecting Meta. Investors should closely monitor news and company announcements.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue     |
| :---------- | :--- | :---------- |
| 2025-05-01 | 6.59 | $42.31B     |
| 2024-10-31 | 6.2  | $40.59B     |
| 2024-08-01 | 5.31 | $39.07B     |
| 2024-04-25 | 4.86 | $36.45B     |
| 2025-05-01 | 4.86 | $36.45B     |

**Analysis:** The data suggests an increasing trend in both EPS (Earnings Per Share) and revenue, indicating positive financial performance in recent quarters.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| :----------- | :--------- | :-------------- |
| 2025-03-31 | \$42.31B | 82.11%        |
| 2024-12-31 | \$48.38B | 81.73%        |
| 2024-09-30 | \$40.59B | 81.83%        |
| 2024-06-30 | \$39.07B | 81.30%        |
| 2024-03-31 | \$36.45B | 81.79%        |

**Analysis:** Revenue has generally increased over the last five quarters, peaking in 2024-12-31. The profit margin remains consistently high, indicating strong profitability.

**Capital and Profitability:**

| Quarter      | Equity       | ROE      |
| :----------- | :------------ | :------- |
| 2025-03-31 | \$185.03B   | 9.00%    |
| 2024-12-31 | \$182.64B   | 11.41%   |
| 2024-09-30 | \$164.53B   | 9.54%    |
| 2024-06-30 | \$156.76B   | 8.59%    |
| 2024-03-31 | \$149.53B   | 8.27%    |

**Analysis:** Equity has been steadily increasing, reflecting growth in the company's net assets. Return on Equity (ROE) fluctuates but remains healthy, indicating the company's efficiency in generating profits from shareholders' equity.

### 7. Overall Analysis & Summary

Meta Platforms Inc. (META) is currently demonstrating strong financial performance and positive market sentiment. The company has significantly outperformed the S&P 500, driven by revenue and EPS growth.

**Key Observations:**

*   **Positive Trends:** The stock shows positive short-term and long-term price trends. The recent earnings reports and financial data indicate strong profitability and growth.
*   **High Volatility:** Recent news suggests the potential for continued volatility, and the large Maximum Drawdowns (MDD) in historical performance highlight the risk of significant losses.
*   **Cautious Signals:** Despite the positive trends, the Hybrid Signal recommends caution and a high cash position. The expected underperformance compared to the S&P 500 and the negative delta in relative divergence are concerning.
*   **Market Risk:** The low-risk MRI suggests a stable market environment, but investors should monitor news and company announcements closely due to potential volatility.

**Recommendations:**

*   **Monitor News:** Keep a close watch on news and company announcements regarding regulatory changes, market events, and business developments.
*   **Assess Risk Tolerance:** Evaluate your risk tolerance given the historical volatility and potential for future market fluctuations.
*   **Consider Diversification:** Diversify your portfolio to mitigate risks associated with META's performance.

**Disclaimer:** This is an AI-generated analysis based on the provided data and should not be considered financial advice.  Please consult with a qualified financial advisor before making any investment decisions.
